StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories fDA MAUDE MDR Reports — Patient Injury (Abbott)

U.S. FDA openFDA MAUDE Database

Latest, FY2025
32,017
Period ended Dec 31, 2025
Change on a year earlier
-20.7%
40,374 in FY2024
History
12 years
Since FY2014
Sources
1
U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Abbott Laboratories FDA MAUDE MDR Reports — Patient Injury (Abbott), annual FY2014–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ext-fda-maude-inj

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.